Lourdes Felix
Chief Executive Officer bij BIOCORRX INC.
Vermogen: 123 619 $ op 31-03-2024
Actieve functies van Lourdes Felix
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOCORRX INC. | Director/Board Member | 07-03-2013 | - |
| Chief Executive Officer | 09-11-2020 | - | |
| Chief Operating Officer | - | - | |
| Director of Finance/CFO | 01-10-2012 | - | |
| Comptroller/Controller/Auditor | - | 02-03-2020 | |
| President | 26-02-2020 | 09-11-2020 | |
| Treasurer | 01-10-2012 | 17-06-2016 | |
| SIYATA MOBILE INC. | Director/Board Member | 29-10-2021 | - |
| Independent Dir/Board Member | 29-10-2021 | - | |
| LICHEN CHINA LIMITED | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - | |
| AVALON GLOBOCARE CORP. | Director/Board Member | 09-01-2023 | - |
| Independent Dir/Board Member | 09-01-2023 | - | |
| LA ROSA HOLDINGS CORP. | Director/Board Member | 17-04-2024 | - |
| Independent Dir/Board Member | 17-04-2024 | - | |
BioCorRx Pharmaceuticals, Inc.
 BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The private company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Director/Board Member | - | - |
| Chief Operating Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Founder | - | - | |
| President | - | - | |
Vocodia Holdings Corp.
 Vocodia Holdings Corp. Packaged SoftwareTechnology Services Vocodia Holdings Corp. engages in the provision of conversational artificial intelligence technology. The firm is also involved in building practical artificial intelligence functions and makes them easily obtainable for businesses on cloud-based platform solutions at low costs and scalable to multiagent vast enterprise solutions. The company was founded by Brian Podolak and James Sposato on April 27, 2021 and is headquartered in Boca Raton, FL. | Director/Board Member | 22-02-2024 | - |
| Independent Dir/Board Member | 22-02-2024 | - |
Loopbaan van Lourdes Felix
Opleiding van Lourdes Felix
| University of Phoenix | Undergraduate Degree |
| D'Amore-Mckim School of Business | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Canada | 2 |
| China | 2 |
Operationeel
| Director/Board Member | 7 |
| Independent Dir/Board Member | 5 |
| Chief Operating Officer | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 6 |
|---|---|
| BIOCORRX INC. | Health Services |
| AVALON GLOBOCARE CORP. | Health Technology |
| SIYATA MOBILE INC. | Electronic Technology |
| LICHEN CHINA LIMITED | Commercial Services |
 | Technology Services |
| LA ROSA HOLDINGS CORP. | Finance |
| Bedrijven in privébezit | 1 |
|---|---|
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The private company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Health Technology |
- Beurs
- Insiders
- Lourdes Felix
- Ervaring
